532
Views
3
CrossRef citations to date
0
Altmetric
Review Article

Pharmaceutical, biomedical and ophthalmic applications of biodegradable polymers (BDPs): literature and patent review

, , & ORCID Icon
Pages 341-356 | Received 29 Nov 2021, Accepted 01 Mar 2022, Published online: 03 Apr 2022

References

  • Abdelkader H, Alani AW, Alany RG. 2014. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv. 21(2):87–100.
  • Abdelkader H, Ismail S, Kamal A, Alany RG. 2011. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci. 100(5):1833–1846.
  • Abdelkader H, Wertheim D, Pierscionek B, Alany RG. 2020. Curcumin in situ gelling polymeric insert with enhanced ocular performance. Pharmaceutics. 12(12):1158.
  • Abdelkader H, Wu Z, Al-Kassas R, Alany RG. 2012. Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. Int J Pharm. 433(1–2):142–148.
  • Agarwal R, Iezhitsa I, Agarwal P, Alimah Abdul Nasir N, Razali N, Alyautdin R, Mohd Ismail N. 2016. Drug delivery liposomes in topical ophthalmic drug delivery: an update liposomes in topical ophthalmic drug delivery: an update. Drug Deliv. 23(4):1075–1091.
  • Agrahari V, Mandal A, Agrahari V, Trinh HM, Joseph M, Ray A, Hadji H, Mitra R, Pal D, Mitra AK. 2016. A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res. 6(6):735–754.
  • Akaraonye E, Keshavarz T, Roy I. 2010. Production of polyhydroxyalkanoates: the future green materials of choice. J Chem Technol Biotechnol. 85(6):732–743.
  • Al Khateb K, Ozhmukhametova EK, Mussin MN, Seilkhanov SK, Rakhypbekov TK, Lau WM, Khutoryanskiy VV. 2016. In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery. Int J Pharm. 502(1-2):70–79.
  • Alazar N, Ghebremeskel Spada LT, Allergan, Inc. 2014 May 6. Solvent cast film sustained release latanoprost implant. United State patent. US 8,715,713. Irvine, CA (US).
  • Alghamdi EAS, Al Qahtani AY, Sinjab MM, Alyahya KM, Alghamdi EAS, Al Qahtani AY, Sinjab MM, Alyahya KM. 2020. Factors affecting bioavailability and efficacy of topical ophthalmic preparations. In: Extemporaneous ophthalmic prep. Cham: Springer International Publishing; p. 5–7.
  • Ali A, Ahmed S. 2018. A review on chitosan and its nanocomposites in drug delivery. Int J Biol Macromol. 109:273–286.
  • Al-Kinani AA, Calabrese G, Vangala A, Naughton D, Alany RG. 2012. Nanotechnology in ophthalmic drug delivery. In: Patenting nanomedicines. Berlin (Heidelberg): Springer; p. 277–303.
  • Al-Kinani AA, Naughton DP, Calabrese G, Vangala A, Smith JR, Pierscionek BK, Alany RG. 2015. Analysis of 2-oxothiazolidine-4-carboxylic acid by hydrophilic interaction liquid chromatography: application for ocular delivery using chitosan nanoparticles. Anal Bioanal Chem. 407(9):2645–2650.
  • Allam A, El-Mokhtar MA, Elsabahy M. 2019. Vancomycin-loaded niosomes integrated within pH-sensitive in-situ forming gel for treatment of ocular infections while minimizing drug irritation. J Pharm Pharmacol. 71(8):1209–1221.
  • Almeida H, Amaral MH, Lobão P, Lobo JMS. 2014. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. Drug Discov Today. 19(4):400–412.
  • Almeida H, Amaral MH, Lobão P, Sousa Lobo JM. 2013. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview. Expert Opin Drug Deliv. 10(9):1223–1237.
  • Annunziata M, Nastri L, Cecoro G, Guida L. 2017. The use of poly-D, L-lactic acid (PDLLA) devices for bone augmentation techniques: a systematic review. Molecules. 22(12):2214.
  • Arakawa CK, DeForest CA. 2017. Polymer design and development. In: Biology and engineering of stem cell niches. Amsterdam: Elsevier Inc.; p. 295–314.
  • Aramwit P. 2016. Introduction to biomaterials for wound healing. In: Wound healing biomaterials. Vol. 2. Amsterdam: Elsevier Inc.; p. 3–38.
  • Balazs DA, Godbey WT. 2011. Liposomes for use in gene delivery. J Drug Deliv. 2011:326497–326412.
  • Başaran E, Yenilmez E, Berkman MS, Büyükköroğlu G, Yazan Y. 2014. Chitosan nanoparticles for ocular delivery of cyclosporine A. J Microencapsul. 31(1):49–57.
  • Bennett L. 2016. Topical versus systemic ocular drug delivery. In: Ocular drug delivery: advances, challenges and applications. Cham: Springer International Publishing; p. 53–74.
  • Blackbourne LH, Butler FK. 2016. Damage control: prehospital care of the patient with vascular injury. Richs Vasc Trauma. 183–197.
  • Blasi P. 2019. Poly(lactic acid)/poly(lactic-co-glycolic acid)-based microparticles: an overview. J Pharm Investig. 49(4):337–346.
  • Bliley JM, Marra KG. 2015. Polymeric biomaterials as tissue scaffolds. In: Stem cell biology and tissue engineering in dental sciences. Boston: Elsevier Inc.; p. 149–161.
  • Boia R, Dias PAN, Martins JM, Galindo-Romero C, Aires ID, Vidal-Sanz M, Agudo-Barriuso M, de Sousa HC, Ambrósio AF, Braga MEM, et al. 2019. Porous poly(ε-caprolactone) implants: a novel strategy for efficient intraocular drug delivery. J Control Release. 316:331–348.
  • Bromberg LE, Ron ES. 1998. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv Drug Deliv Rev. 31(3):197–221.
  • Butt U, ElShaer A, Snyder LAS, Al-Kinani AA, Le Gresley A, Alany RG. 2018. Fatty acid based microemulsions to combat ophthalmia neonatorum caused by Neisseria gonorrhoeae and Staphylococcus aureus. Nanomaterials. 8(1):51.
  • Chaudhary C, Garg T. 2015. Scaffolds: a novel carrier and potential wound healer. Crit Rev Ther Drug Carrier Syst. 32(4):277–321.
  • Caires HR, Esteves T, Quelhas P, Barbosa MA, Navarro M, Almeida CR. 2016. Macrophage interactions with polylactic acid and chitosan scaffolds lead to improved recruitment of human mesenchymal stem/stromal cells: a comprehensive study with different immune cells. J R Soc Interface. 13(122):20160570.
  • Cameron RE, Kamvari-Moghaddam A. 2012. Synthetic bioresorbable polymers. In: Mike Jenkins, Artemis Stamboulis, editors. Durability and reliability of medical polymers. Amsterdam: Elsevier; p. 96–118.
  • Cañadas C, Alvarado H, Calpena AC, Silva AM, Souto EB, García ML, Abrego G. 2016. In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration. Int J Pharm. 511(2):719–727.
  • Chang J, Gupta G. 2010. Tissue engineering for the hand: research advances and clinical applications. London: World Scientific Publishing Co.
  • Chien CS, Ho HO, Liang YC, Ko PH, Sheu MT, Chen CH. 2012. Incorporation of exudates of human platelet-rich fibrin gel in biodegradable fibrin scaffolds for tissue engineering of cartilage. J Biomed Mater Res B Appl Biomater. 100(4):948–955.
  • Chopra S, Venkatesan N, Betageri GV. 2013. Liposomes as nanocarriers for anti-HIV therapy. Drug Deliv Transl Res. 3(5):471–478.
  • Chu CC. 2013. Materials for absorbable and nonabsorbable surgical sutures. In: Biotextiles as medical implants. Amsterdam: Elsevier Inc.; p. 275–334.
  • Deng M, Kumbar SG, Wan Y, Toti US, Allcock HR, Laurencin CT. 2010. Polyphosphazene polymers for tissue engineering: an analysis of material synthesis, characterization and applications. Soft Matter. 6(14):3119–3132.
  • Deshayes S, Kasko AM. 2013. Polymeric biomaterials with engineered degradation. J Polym Sci Part A: Polym Chem. 51(17):3531–3566.
  • Dicker KT, Gurski LA, Pradhan-Bhatt S, Witt RL, Farach-Carson MC, Jia X. 2014. Hyaluronan: a simple polysaccharide with diverse biological functions. Acta Biomater. 10(4):1558–1570.
  • Dmour I, Taha MO. 2018. Natural and semisynthetic polymers in pharmaceutical nanotechnology. In: Alexandru Mihai Grumezescu, editor. Organic materials as smart nanocarriers for drug delivery. Amsterdam: Elsevier Inc.; p. 35–100.
  • Doppalapudi S, Jain A, Khan W, Domb AJ. 2014. Biodegradable polymers-an overview. Polym Adv Technol. 25(5):427–435.
  • Duan K, Zhang X, Tang X, Yu J, Liu S, Wang D, Li Y, Huang J. 2010. Fabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecin. Colloids Surf B Biointerfaces. 76(2):475–482.
  • Duarte AP, Coelho JF, Bordado JC, Cidade MT, Gil MH. 2012. Surgical adhesives: systematic review of the main types and development forecast. Prog Polym Sci. 37(8):1031–1050.
  • Edelman JL, Hughes PM, Malone TC, DeVries GW, Chang-Lin J-E, Shiah J-G, Nivaggioli T, Spada LT, Blanda WM, Allergan, Inc. 2013 Aug 20. Biodegradable intravitreal tyrosine kinase implants. United States, US20160199297.
  • El Hoffy NM, Abdel Azim EA, Hathout RM, Fouly MA, Elkheshen SA. 2021. Glaucoma: management and future perspectives for nanotechnology-based treatment modalities. Eur J Pharm Sci. 158:105648.
  • El Maghraby GM, Arafa MF. 2019. Alginate-chitosan combinations in controlled drug delivery. In: Natural polysaccharides in drug delivery and biomedical applications. Amsterdam: Elsevier; p. 339–361.
  • Esquivel R, Juárez J, Almada M, Ibarra J, Valdez MA. 2015. Synthesis and characterization of new thiolated chitosan nanoparticles obtained by ionic gelation method. Int J Polym Sci. 2015:1–18.
  • Fernández-Sánchez L, Bravo-Osuna I, Lax P, Arranz-Romera A, Maneu V, Esteban-Pérez S, Pinilla I, Puebla-González M. d M, Herrero-Vanrell R, Cuenca N. 2017. Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration. PLOS One. 12(5):e0177998.
  • Figueiredo P, Almeida BC, Carvalho ATP. 2019. Enzymatic polymerization of PCL-PEG Co-polymers for biomedical applications. Front Mol Biosci. 6:109–107.
  • Fonseca AC, Serra AC, Coelho JFJ. 2015. Bioabsorbable polymers in cancer therapy: latest developments. EPMA J. 6(1):1–18.
  • Fujisawa T, Miyai H, Hironaka K, Tsukamoto T, Tahara K, Tozuka Y, Ito M, Takeuchi H. 2012. Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes. Int J Pharm. 436(1–2):564–567.
  • Garg U, Chauhan S, Nagaich U, Jain N. 2019. Current advances in chitosan nanoparticles based drug delivery and targeting. Adv Pharm Bull. 9(2):195–204.
  • Gaudana R, Ananthula HK, Parenky A, Mitra AK. 2010. Ocular drug delivery. Aaps J. 12(3):348–360.
  • Ge X, Wei M, He S, Yuan W-E. 2019. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics. 11(2):55.
  • George A, Shah PA, Shrivastav PS. 2019. Natural biodegradable polymers based nano-formulations for drug delivery: a review. Int J Pharm. 561:244–264.
  • Gharbavi M, Amani J, Kheiri-Manjili H, Danafar H, Sharafi A. 2018. Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier. Adv Pharmacol Sci. 2018:6847971.
  • Ginjupalli K, Shavi GV, Averineni RK, Bhat M, Udupa N, Nagaraja Upadhya P. 2017. Poly(α-hydroxy acid) based polymers: a review on material and degradation aspects. Polym Degrad Stab. 144:520–535.
  • Glaser JA. 2019. Biological degradation of polymers in the environment. In: Alessio Gmiero, editor. Plast Inenviroment. Vol. 1. London (UK): IntechOpen; p. 73–93.
  • Gooch N, Molokhia SA, Condie R, Burr RM, Archer B, Ambati BK, Wirostko B. 2012. Ocular drug delivery for glaucoma management. Pharmaceutics. 4(1):197–211.
  • Gorth D, Webster TJ. 2010. Matrices for tissue engineering and regenerative medicine. In: Biomater Artif Organs. Amsterdam: Elsevier Inc.; p. 270–286.
  • Gu L, Shan T, Ma Y. x, Tay FR, Niu L. 2019. Novel biomedical applications of crosslinked collagen. Trends Biotechnol. 37(5):464–491.
  • Gunatillake PA, Adhikari R, Gadegaard N. 2003. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater. 5(1):1–16.
  • Gupta H, Aqil M, Khar R, Ali A, Bhatnagar A, Mittal G. 2015. An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention. J Pharm Bioallied Sci. 7(1):9–14.
  • Habib FS, Fouad EA, Abdel‐Rhaman MS, Fathalla D. 2010. Liposomes as an ocular delivery system of fluconazole: in-vitro studies. Acta Ophthalmol. 88(8):901–904.
  • Han F, Zhu C, Chen L, Wicks J, Li B. 2017. Bio-instructive scaffolds for bone regeneration. In: Justin Brown, Sangamesh Kumbar, Brittany Banik, editors. Bio-instructive scaffolds for musculoskeletal tissue engineering and regenerative medicine. Amsterdam: Elsevier Inc.; p. 55–84.
  • Hickey RJ, Pelling AE. 2019. Cellulose biomaterials for tissue engineering. Front Bioeng Biotechnol. 7:45–45.
  • Highley CB, Prestwich GD, Burdick JA. 2016. Recent advances in hyaluronic acid hydrogels for biomedical applications. Curr Opin Biotechnol. 40:35–40.
  • H.S. Boddu S. 2012. Polymeric nanoparticles for ophthalmic drug delivery: an update on research and patenting activity. PNM. 2(2):96–112.
  • http://fyra.io. Drug delivery to the posterior segment: an update – retina today. https://retinatoday.com/articles/2013-july-aug/drug-delivery-to-the-posterior-segment-an-update.
  • Huang D, Chen YS, Rupenthal ID. 2018. Corrigendum to “Overcoming ocular drug delivery barriers through the use of physical forces” (Advanced Drug Delivery Reviews (2018) 126 (96–112), (S0169409X17301898), (10.1016/j.addr.2017.09.008)). Adv Drug Deliv Rev. 126:96–157.
  • Ibrahim MM, Abd-Elgawad AEH, Soliman OA, Jablonski MM. 2013. Novel topical ophthalmic formulations for management of glaucoma. Pharm Res. 30(11):2818–2831.
  • Id R, Cr G, Rg A. 2011. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release. Int J Pharm. 411(1–2):69–77.
  • Imazato S, Kitagawa H, Tsuboi R, Kitagawa R, Thongthai P, Sasaki J. i. 2017. Non-biodegradable polymer particles for drug delivery: a new technology for “bio-active” restorative materials. Dent Mater J. 36(5):524–532.
  • Irimia T, Dinu-Pîrvu CE, Ghica MV, Lupuleasa D, Muntean DL, Udeanu DI, Popa L. 2018. Chitosan-based in situ gels for ocular delivery of therapeutics: a state-of-the-art review. Mar Drugs. 16(10):373.
  • Irimia T, Ghica MV, Popa L, Anuţa V, Arsene AL, Dinu-Pîrvu CE. 2018. Strategies for improving ocular drug bioavailability and cornealwound healing with chitosan-based delivery systems. Polymers. 10(11):1221.
  • Jafariazar Z, Jamalinia N, Ghorbani-Bidkorbeh F, Mortazavi SA. 2015. Design and evaluation of ocular controlled delivery system for diclofenac sodium. Iran J Pharm Res. 14(Suppl):23–31.
  • Jain A, Reddy Kunduru K, Basu A, Mizrahi B, Domb AJ, Khan W. 2016. Injectable formulations of poly(lactic acid) and its copolymers in clinical use ⋆. Adv Drug Deliv Rev. 107:213–227.
  • Jain D, Carvalho E, Banthia AK, Banerjee R. 2011. Development of polyvinyl alcohol-gelatin membranes for antibiotic delivery in the eye. Drug Dev Ind Pharm. 37(2):167–177.
  • Jain GK, Pathan SA, Akhter S, Jayabalan N, Talegaonkar S, Khar RK, Ahmad FJ. 2011. Microscopic and spectroscopic evaluation of novel PLGA-chitosan nanoplexes as an ocular delivery system. Colloids Surf B Biointerfaces. 82(2):397–403.
  • Jain K, Kumar R, Sood S, Dhyanandhan G. 2013. Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy. CDD. 10(5):493–499.
  • Jarrett P, Bassett M, Blizzard CD, Sawhney AS, Incept, LLC. 2013 Apr 2. Drug delivery through hydrogel plugs. United State patent, US20130172268.
  • Jiang S, Liu S, Feng W. 2011. PVA hydrogel properties for biomedical application. J Mech Behav Biomed Mater. 4(7):1228–1233.
  • Jin SE, Hwang SJ. 2017. Ocular delivery systems for the administration of antibody therapeutics. J Pharm Investig. 47(5):373–382.
  • Jin Y-J, Ubonvan T, Kim D-D. 2010. Hyaluronic acid in drug delivery systems. J Pharm Investig. 40(spc):33–33.
  • John P, Lazarus F, George JP, Selvam A, Prabhuji MLV. 2015. Adjunctive effects of a piscean collagen-based controlled-release chlorhexidine chip in the treatment of chronic periodontitis: a clinical and microbiological study. J Clin Diagn Res. 9(5):ZC70–ZC70.
  • Kaiser JM, Imai H, Haakenson JK, Brucklacher RM, Fox TE, Shanmugavelandy SS, Unrath KA, Pedersen MM, Dai P, Freeman WM, et al. 2013. Nanoliposomal minocycline for ocular drug delivery. Nanomedicine. 9(1):130–140.
  • Kamaly N, Yameen B, Wu J, Farokhzad OC. 2016. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 116(4):2602–2663.
  • Kattula S, Byrnes JR, Wolberg AS. 2017. Fibrinogen and fibrin in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 37(3):e13–e21.
  • Kaur IP, Smitha R. 2002. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm. 28(4):353–369.
  • Kesavan K, Kant S, Singh PN, Pandit JK. 2013. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation. Curr Eye Res. 38(3):342–352.
  • Cuevas KH, InSight Innovations LLC. 2011 Sep1: 22. Biocompatible Biodegradable Intraocular Implant System. United States patent application US, 12/998,652.
  • Khoder M, Abdelkader H, ElShaer A, Karam A, Najlah M, Alany RG. 2018. The use of albumin solid dispersion to enhance the solubility of unionizable drugs. Pharm Dev Technol. 23(7):732–738.
  • Khoder M, Gbormoi HK, Ryan A, Karam A, Alany RG. 2019. Potential use of the maillard reaction for pharmaceutical applications: gastric and intestinal controlled release alginate-albumin beads. Pharmaceutics. 11(2):83.
  • Khutoryanskaya OV, Morrison PWJ, Seilkhanov SK, Mussin MN, Ozhmukhametova EK, Rakhypbekov TK, Khutoryanskiy VV. 2014. Hydrogen-bonded complexes and blends of poly(acrylic acid) and methylcellulose: nanoparticles and mucoadhesive films for ocular delivery of riboflavin. Macromol Biosci. 14(2):225–234.
  • Kim D, Thangavelu M, Baek JS, Kim HS, Choi MJ, Cho HH, Song JE, Khang G. 2020. Fabrication of POX/PLGA scaffold for the potential application of tissue engineering and cell transplantation. Macromol Res. 28(3):196–202.
  • Kim MS, Kim G. 2014. Three-dimensional electrospun polycaprolactone (PCL)/alginate hybrid composite scaffolds. Carbohydr Polym. 114:213–221.
  • Kocak G, Tuncer C, Bütün V. 2017. PH-Responsive polymers. Polym Chem. 8(1):144–176.
  • Kulig D, Zimoch-Korzycka A, Jarmoluk A, Marycz K. 2016. Study on alginate–chitosan complex formed with different polymers ratio. Polymers. 8(5):167–167.
  • Kumar D, Jain N, Gulati N, Nagaich U. 2013. Nanoparticles laden in situ gelling system for ocular drug targeting. J Adv Pharm Technol Res. 4(1):9–17.
  • Kushwaha S, Rai A, Saxena P. 2012. Stimuli sensitive hydrogels for ophthalmic drug delivery: a review. Int J Pharm Investig. 2(2):54–54.
  • Laddha U, Mahajan H. 2017. An insight to ocular in situ gelling systems. Int J Adv Pharm. 6(02):31–40.
  • Lai S, Wei Y, Wu Q, Zhou K, Liu T, Zhang Y, Jiang N, Xiao W, Chen J, Liu Q, et al. 2019. Liposomes for effective drug delivery to the ocular posterior chamber. J Nanobiotechnology. 17(1):64–64.
  • Lancina MG, Yang H. 2017. Dendrimers for ocular drug delivery. Can J Chem. 95(9):897–902.
  • Landsman AS, Cook J, Cook E, Landsman AR, Garrett P, Yoon J, Kirkwood A, Desman E. 2011. A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin®) on the treatment of diabetic foot ulcers and venous leg ulcers. Foot Ankle Spec. 4(1):29–41.
  • Larsen MT, Kuhlmann M, Hvam ML, Howard KA. 2016. Albumin-based drug delivery: harnessing nature to cure disease. Mol Cell Ther. 4(1):3.
  • Lee H, Lee JH, Jeon CS, Ko JH, Park SN, Lee YT. 2019. Evaluation of a novel collagen hemostatic matrix in a porcine heart and cardiac vessel injury model. J Thorac Dis. 11(7):2722–2729.
  • Lee JB, Kim JE, Bae MS, Park SA, Balikov DA, Sung HJ, Jeon HB, Park HK, Um SH, Lee KS, et al. 2016. Development of poly(ε-Caprolactone) scaffold loaded with simvastatin and beta-cyclodextrin modified hydroxyapatite inclusion complex for bone tissue engineering. Polymers. 8(2):49.
  • Li J, Cai C, Li J, Li J, Li J, Sun T, Wang L, Wu H, Yu G. 2018. Chitosan-based nanomaterials for drug delivery. Molecules. 23(10):2661.
  • Li Y, Meng H, Liu Y, Lee BP. 2015. Fibrin gel as an injectable biodegradable scaffold and cell carrier for tissue engineering. ScientificWorldJournal. 2015:685690.
  • Lidich N, Garti-Levy S, Aserin A, Garti N. 2019. Potentiality of microemulsion systems in treatment of ophthalmic disorders: keratoconus and dry eye syndrome – in vivo study. Colloids Surf B Biointerfaces. 173:226–232.
  • Lin CC, Anseth KS. 2013. The biodegradation of biodegradable polymeric biomaterials. In: Biomater Sci Introd Mater Third Ed. Massachusett: Academic Press; p. 716–728.
  • Lipsa R, Tudorachi N, Vasile C. 2010. Poly(α-hydroxyacids) in biomedical applications: synthesis and properties of lactic acid polymers. E-Polym. 10(1):087.
  • Litvinov RI, Weisel JW. 2016. What is the biological and clinical relevance of fibrin? Semin Thromb Hemost. 42(4):333–343.
  • Liu H, Wan J, Hughes PM, Allergan, Inc. 2017 Mar 16. Microsphere drug delivery system for sustained intraocular release. United State patent: US 0071953.
  • Liu YC, Peng Y, Lwin NC, Wong TT, Venkatraman SS, Mehta JS. 2013. Optimization of subconjunctival biodegradable microfilms for sustained drug delivery to the anterior segment in a small animal model. Invest Ophthalmol Vis Sci. 54(4):2607–2615.
  • Loftsson T, Jansook P, Stefánsson E. 2012. Topical drug delivery to the eye: dorzolamide. Acta Ophthalmol. 90(7):603–608.
  • Lynch C, Kondiah PPD, Choonara YE, Du Toit LC, Ally N, Pillay V. 2019. Advances in biodegradable nano-sized polymer-based ocular drug delivery. Polymers. 11(8):1371.
  • Makadia HK, Siegel SJ. 2011. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 3(3):1377–1397.
  • Makwana SB, Patel VA, Parmar SJ. 2016. Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride. Results Pharma Sci. 6:1–6.
  • Malikmammadov E, Tanir TE, Kiziltay A, Hasirci V, Hasirci N. 2018. PCL and PCL-based materials in biomedical applications. J Biomater Sci Polym Ed. 29(7–9):863–893.
  • Manavitehrani I, Fathi A, Badr H, Daly S, Shirazi AN, Dehghani F. 2016. Biomedical applications of biodegradable polyesters. Polymers. 8(1):20.
  • Manickavasagam D, Oyewumi MO. 2013. Critical assessment of implantable drug delivery devices in glaucoma management. J Drug Deliv. 2013:895013–895012.
  • Martins AF, Facchi SP, Follmann HDM, Pereira AGB, Rubira AF, Muniz EC. 2014. Antimicrobial activity of chitosan derivatives containing N-quaternized moieties in its backbone: a review. Int J Mol Sci. 15(11):20800–20832.
  • Matica A, Menghiu G, Ostafe V. 2017. Biodegradability of chitosan based products. Former Ann West Univ Timisoara-Ser Chem. 26(1):75–86.
  • Mazyed EA, Abdelaziz AE. 2020. Fabrication of transgelosomes for enhancing the ocular delivery of acetazolamide: Statistical optimization, in vitro characterization, and in vivo study. Pharmaceutics. 12(5):465.
  • Mello RS, Bedendo GC, Nome F, Fiedler HD, Laranjeira MCM. 2006. Preparation of chitosan membranes for filtration and concentration of compounds under high pressure process. Polym Bull. 56(4–5):447–454.
  • Mishra PK, Ashoub A, Salhiyyah K, Aktuerk D, Ohri S, Raja SG, Luckraz H. 2014. Role of topical application of gentamicin containing collagen implants in cardiac surgery. J Cardiothorac Surg. 9(1):122–122.
  • Moiseev RV, Morrison PWJ, Steele F, Khutoryanskiy VV. 2019. Penetration enhancers in ocular drug delivery. Pharmaceutics. 11(7):321.
  • de Moraes Porto ICC. 2012. Polymer biocompatibility. In: Ailton De Souza Gomes, editor. Polymerization. Rijeka: InTech; p. 47–62.
  • Mostafavi S, Karkhane R, Riazi-Esfahani M, Dorkoosh F, Rafiee-Tehrani M, Tamaddon L. 2015. Design and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditis. Adv Biomed Res. 4(1):32–32.
  • Musumeci T, Bucolo C, Carbone C, Pignatello R, Drago F, Puglisi G. 2013. Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits. Int J Pharm. 440(2):135–140.
  • Mutalabisin MF, Chatterjee B, Jaffri JM. 2018. pH responsive polymers in drug delivery. Rese J Pharm Technol. 11(11):5115–5122.
  • Nagarwal RC, Kumar R, Pandit JK. 2012. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye. Eur J Pharm Sci. 47(4):678–685.
  • Nagarwal RC, Singh PN, Kant S, Maiti P, Pandit JK. 2011. Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study. Chem Pharm Bull. 59(2):272–278.
  • Navaei T, Milan PB, Davari HR, Samadikuchaksaraei A, Mozafari M. 2018. Nanoengineered biomaterials for diaphragm regeneration. In: Nanoeng Biomater Regen Med. Amsterdam: Elsevier; p. 345–362.
  • Nickel JC, Jain P, Shore N, Anderson J, Giesing D, Lee H, Kim G, Daniel K, White S, Larrivee-Elkins C. 2012. Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device. Sci Transl Med. 4(143):143ra100-143ra100.
  • Niemelä T, Kellomäki M. 2011. Bioactive glass and biodegradable polymer composites. Bioact Glas Mater Prop Appl. 227–245.
  • Olusanya TOB, Ahmad RRH, Ibegbu DM, Smith JR, Elkordy AA. 2018. Liposomal drug delivery systems and anticancer drugs. Molecules. 23(4):907.
  • Pearce W, Hsu J, Yeh S. 2015. Advances in drug delivery to the posterior segment. Curr Opin Ophthalmol. 26(3):233–239.
  • Prata AI, Coimbra P, Pina ME. 2018. Preparation of dexamethasone ophthalmic implants: a comparative study of in vitro release profiles. Pharm Dev Technol. 23(3):218–224.
  • Prestwich GD. 2011. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine. J Control Release. 155(2):193–199.
  • Rashid TU, Sharmeen S, Biswas S, Ahmed T, Mallik AK, Shahruzzaman M, Sakib MN, Haque P, Rahman MM. 2019. Gelatin-based hydrogels. In: Cham: Springer; p. 1601–1641.
  • Raval JP, Naik DR, Amin KA, Patel PS. 2014. Controlled-release and antibacterial studies of doxycycline-loaded poly(ε-caprolactone) microspheres. J Saudi Chem Soc. 18(5):566–573.
  • Robert T, Lyons RT, Burke JA, Robinson MR, Allergan, Inc. 2015 Feb 17. Biodegradable drug delivery system. United States, US 8,956,655.
  • Robinson MR, Liu H, Hughes PM, Spada LT, Ghebremeskel Alazar N, Allergan Inc. 2010 Apr 29. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof. United States, US20140314868.
  • Rodríguez Villanueva J, Bravo-Osuna I, Herrero-Vanrell R, Molina Martínez IT, Guzmán Navarro M. 2016. Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration. Eur J Pharm Sci. 92:287–297.
  • Rubalskii E, Ruemke S, Salmoukas C, Aleshkin A, Bochkareva S, Modin E, Mashaqi B, Boyle EC, Boethig D, Rubalsky M, et al. 2019. Fibrin glue as a local drug-delivery system for bacteriophage PA5. Sci Rep. 9(1):1–8.
  • Rupenthal ID, Alany RG. 2007. Ocular drug delivery. In: Pharmaceutical manufacturing handbook: production and processes. New Jersey (US): John Wiley & Sons, Inc.; p. 729–767.
  • Rupenthal ID, Alany RG, Green CR. 2011. Ion-activated in situ gelling systems for antisense oligodeoxynucleotide delivery to the ocular surface. Mol Pharm. 8(6):2282–2290.
  • Sampat K. 2010 ophthalmology SG-C opinion. undefined. Complications of intravitreal injections. journals.lww.com. https://journals.lww.com/co-ophthalmology/fulltext/2010/05000/Complications_of_intravitreal_injections.4.aspx.
  • Santos AMN, Moreira APD, Carvalho CWP, Luchese R, Ribeiro E, McGuinness GB, Mendes MF, Oliveira RN. 2019. Physically cross-linked gels of PVA with natural polymers as matrices for manuka honey release in wound-care applications. Materials. 12(4):559.
  • dos Santos GA, Ferreira-Nunes R, Dalmolin LF, dos Santos Ré AC, Anjos JLV, Mendanha SA, Aires CP, Lopez RFV, Cunha-Filho M, Gelfuso GM, et al. 2020. Besifloxacin liposomes with positively charged additives for an improved topical ocular delivery. Sci Rep. 10(1):19285–19285.
  • Schoubben A, Ricci M, Giovagnoli S. 2019. Meeting the unmet: from traditional to cutting-edge techniques for poly lactide and poly lactide-co-glycolide microparticle manufacturing. J Pharm Investig. 49(4):381–404.
  • Sezer S, Şahin İ, Öztürk K, Şanko V, Koçer Z, Sezer ÜA. 2019. Cellulose-based hydrogels as biomaterials. Cham: Springer; p. 1177–1203.
  • Shah Shalin S, Denham LV, Elison JR, Bhattacharjee PS, Huq T, Clement C, Hill JM. 2010. Drug delivery to the posterior segment of the eye for pharmacologic therapy. Expert Rev Ophthalmol. 5(1):75–93.
  • Shaikh R, Raj Singh T, Garland M, Woolfson A, Donnelly R. 2011. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 3(1):89–100.
  • Shakeel F, Faisal MS. 2010. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib. Pharm Dev Technol. 15(1):53–56.
  • Shiah J-G, Bhagat R, Blanda M, Peng N, Chou D, Weber A, Allergan Inc. 2013 Aug 13. Ocular implant made by a double extrusion process. United states, US20130295157.
  • Sibilla S, Godfrey M, Brewer S, Budh-Raja A, Genovese L. 2015. An overview of the beneficial effects of hydrolysed collagen as a nutraceutical on skin properties: scientific background and clinical studies. TONUTRAJ. 8(1):29–42.
  • Silva MM, Calado R, Marto J, Bettencourt A, Almeida AJ, Gonçalves LMD. 2017. Chitosan nanoparticles as a mucoadhesive drug delivery system for ocular administration. Mar Drugs. 15(12):370.
  • Smail SS, Ghareeb MM, Omer HK, Al-Kinani AA, Alany RG. 2021. Studies on surfactants, cosurfactants, and oils for prospective use in formulation of ketorolac tromethamine ophthalmic nanoemulsions. Pharmaceutics. 13(4):467–467.
  • Song R, Murphy M, Li C, Ting K, Soo C, Zheng Z. 2018. Current development of biodegradable polymeric materials for biomedical applications. Drug Des Devel Ther. 12:3117–3145.
  • Sousa I, Mendes A, Bártolo PJ. 2013. PCL scaffolds with collagen bioactivator for applications in tissue engineering. Procedia Eng. 59:279–284.
  • Souto EB, Dias-Ferreira J, López-Machado A, Ettcheto M, Cano A, Espuny AC, Espina M, Garcia ML, Sánchez-López E. 2019. Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents. Pharmaceutics. 11(9):460.
  • Spicer PP, Mikos AG. 2010. Fibrin glue as a drug delivery system. J Control Release. 148(1):49–55.
  • Sprowson AP, Aldridge SE, Noakes J, Read JW, Wood DG. 2012. Bio-interference screw cyst formation in anterior cruciate ligament reconstruction-10-year follow up. Knee. 19(5):644–647.
  • Stewart SA, Domínguez-Robles J, Donnelly RF, Larrañeta E. 2018. Implantable polymeric drug delivery devices: classification, manufacture, materials, and clinical applications. Polymers. 10(12):1379.
  • Tamariz E, Rios-Ramrez A. 2013. Biodegradation of medical purpose polymeric materials and their impact on biocompatibility. In: Chamy R, editor. Biodegrad - Life Sci. Rijeka: InTech; p. 3–29.
  • Tamboli V, Mishra GP, Mitra AK. 2012. 3. Biodegradable polymers for ocular drug delivery. https://pdfs.semanticscholar.org/ef89/94f6101798a6a5a7510465ad88554a6b131f.pdf.
  • Tang X, Thankappan SK, Lee P, Fard SE, Harmon MD, Tran K, Yu X. 2014. Polymeric biomaterials in tissue engineering and regenerative medicine. In: Nat Synth Biomed Polym. Amsterdam: Elsevier Inc.; p. 351–371.
  • Terreni E, Chetoni P, Burgalassi S, Tampucci S, Zucchetti E, Chipala E, Alany RG, Al-Kinani AA, Monti D. 2021. A hybrid ocular delivery system of cyclosporine-A comprising nanomicelle-laden polymeric inserts with improved efficacy and tolerability. Biomater Sci. 9(24):8235–8248.
  • Nivaggioli T, Shiah JG, Lin Q, Allergan Inc. 2014 Feb, 6. Extended release biodegradable ocular implants. United State, US 0035184
  • Thrimawithana TR, Young SA, Bunt CR, Green CR, Alany RG. 2011. In-vitro and in-vivo evaluation of carrageenan/methylcellulose polymeric systems for transscleral delivery of macromolecules. Eur J Pharm Sci. 44(3):399–409.
  • Trujillo-de Santiago G, Sharifi R, Yue K, Sani ES, Kashaf SS, Alvarez MM, Leijten J, Khademhosseini A, Dana R, Annabi N. 2019. Ocular adhesives: design, chemistry, crosslinking mechanisms, and applications. Biomaterials. 197:345–367.
  • Tsai CH, Wang PY, Lin IC, Huang H, Liu GS, Tseng CL. 2018. Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application. IJMS. 19(9):2830–2830.
  • Ulery BD, Nair LS, Laurencin CT. 2011. Biomedical applications of biodegradable polymers. J Polym Sci B Polym Phys. 49(12):832–864.
  • Varela-Fernández R, Díaz-Tomé V, Luaces-Rodríguez A, Conde-Penedo A, García-Otero X, Luzardo-Álvarez A, Fernández-Ferreiro A, Otero-Espinar F. 2020. Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations. Pharmaceutics. 12(3):269–269.
  • Vigani B, Rossi S, Sandri G, Bonferoni MC, Caramella CM, Ferrari F. 2020. Recent advances in the development of in situ gelling drug delivery systems for non-parenteral administration routes. Pharmaceutics. 12(9):859–829.
  • Wang N, Chen M, Wang T. 2019. Liposomes used as a vaccine adjuvant-delivery system: from basics to clinical immunization. J Control Release. 303:130–150.
  • Wasilewska K, Winnicka K. 2019. Ethylcellulose-a pharmaceutical excipient with multidirectional application in drug dosage forms development. Materials. 12(20):3386.
  • Welle A, Kröger M, Döring M, Niederer K, Pindel E, Chronakis IS. 2007. Electrospun aliphatic polycarbonates as tailored tissue scaffold materials. Biomaterials. 28(13):2211–2219.
  • Whitcup SM, Robinson MR, Blanda WM, Hughes PM, Burke JA, Allergan Inc. 2019 Jul 30. Method for treating atrophic age related macular degeneration. United State, US20190336441.
  • Wolinsky JB, Colson YL, Grinstaff MW. 2012. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release. 159(1):14–26.
  • Woodruff MA, Hutmacher DW. 2010. The return of a forgotten polymer-Polycaprolactone in the 21st century. http://eprints.qut.edu.au/.
  • Wu H, Liu Z, Peng J, Li L, Li N, Li J, Pan H. 2011. Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery. Int J Pharm. 410(1–2):31–40.
  • Wu Y, Liu Y, Li X, Kebebe D, Zhang B, Ren J, Lu J, Li J, Du S, Liu Z. 2019. Research progress of in-situ gelling ophthalmic drug delivery system. Asian J Pharm Sci. 14(1):1–15.
  • Xu T, Miszuk JM, Zhao Y, Sun H, Fong H. 2015. Electrospun polycaprolactone 3D nanofibrous scaffold with interconnected and hierarchically structured pores for bone tissue engineering. Adv Healthc Mater. 4(15):2238–2246.
  • Xu W, Jiao W, Li S, Tao X, Mu G. 2019. Bimatoprost loaded microemulsion laden contact lens to treat glaucoma. J Drug Deliv Sci Technol. 54:101330–101330.
  • Xu Y, Wang C, Tam KC, Li L. 2004. Salt-assisted and salt-suppressed sol-gel transitions of methylcellulose in water. Langmuir. 20(3):646–652.
  • Song Y, Nagai N, Saijo S, Kaji H, Nishizawa M, Abe T. 2018. In situ formation of injectable chitosan-gelatin hydrogels through double crosslinking for sustained intraocular drug delivery. Mater Sci Eng C Mater Biol Appl. 88:1–12.
  • Yadav D, Varma LT, Yadav K. 2018. Drug delivery to posterior segment of the eye: conventional delivery strategies, their barriers, and restrictions. In: Drug Deliv Retina Posterior Segm Dis. Cham: Springer International Publishing; p. 51–67.
  • Yamada N, Olsen TW. 2015. Routes for drug delivery to the retina: topical, transscleral, suprachoroidal and intravitreal gas phase delivery. In: Dev Ophthalmol. Vol. 55. Basel (Switzerland): S. Karger AG; p. 71–83.
  • Ye Z, Ji YL, Ma X, Wen JG, Wei W, Huang SM. 2015. Pharmacokinetics and distributions of bevacizumab by intravitreal injection of bevacizumab- PLGA microspheres in rabbits. Int J Ophthalmol. 8(4):653–658.
  • You JO, Almeda D, Ye GJC, Auguste DT. 2010. Bioresponsive matrices in drug delivery. J Biol Eng. 4:15.
  • Zadeh MA, Khoder M, Al-Kinani AA, Younes HM, Alany RG. 2019. Retinal cell regeneration using tissue engineered polymeric scaffolds. Drug Discov Today. 24(8):1669–1678.
  • Zhang Z, Ortiz O, Goyal R, Kohn J. 2013. Biodegradable polymers. In: Principles of tissue engineering Fourth Ed. Amsterdam: Elsevier Inc.; p. 441–473.
  • Zhong H, Chan G, Hu Y, Hu H, Ouyang D. 2018. A comprehensive map of FDA-approved pharmaceutical products. Pharmaceutics. 10(4):263.
  • Zhu X, Zhong T, Huang R, Wan A. 2015. Preparation of hydrophilic poly(lactic acid) tissue engineering scaffold via (PLA)-(PLA-b-PEG)-(PEG) solution casting and thermal-induced surface structural transformation. J Biomater Sci Polym Ed. 26(17):1286–1296.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.